| Sep 6, 2023 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) | PACER Document |
| Sep 7, 2023 | ORAL ORDER: It is HEREBY ORDERED that on or before 2 weeks following the entry of appearance by the Defendants, the parties shall either (1) submit to the Clerk of Court an executed Form AO 85 Notice, Consent, and Reference of a Civil Action to a Magistrate Judge, indicating their consent to have a United States Magistrate Judge conduct all proceedings in this case including trial, the entry of final judgment, and post-trial proceedings; or (2) file a joint letter indicating that all the parties do not consent to a referral of this action to a Magistrate Judge. The letter should not indicate which party or parties did not consent. If all the parties consent, the case will be referred to Magistrate Judge Burke. Because of the Court's caseload, if the parties do not consent, the Court intends to assign the case to a visiting judge from another district. Ordered by Judge Colm F. Connolly on 9/7/2023. (nmf) | PACER Document |
| Sep 25, 2023 | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) | PACER Document |
| Sep 25, 2023 | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) | PACER Document |
| Sep 25, 2023 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke's "Rule 16 Scheduling Order - Patent" (and with additional changes made to accommodate the fact that this is an ANDA litigation matter); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Ordered by Judge Christopher J. Burke on 9/25/2023. (dlb) (Entered: 09/25/2023) | PACER Document |
| Oct 17, 2023 | SO ORDERED D.I. 18 STIPULATION TO EXTEND TIME to Submit Case Management Checklist to November 15, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 10/17/2023. (dlb) | PACER Document |
| Oct 18, 2023 | SO ORDERED D.I. 17 MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Joshua E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 10/18/2023. (dlb) | PACER Document |
| Oct 20, 2023 | Pro Hac Vice Attorneys Joshua E. Ney, Mark C. Nelson, and Christina M. Baugh for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) | PACER Document |
| Nov 17, 2023 | SO ORDERED D.I. 19 STIPULATION TO EXTEND TIME to Submit Case Management Checklist to December 6, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 11/17/2023. (dlb) | PACER Document |
| Nov 30, 2023 | SO ORDERED D.I. Nos. (112 in 1:22-cv-01461-CJB, 20 in 1:23-cv-00964-CJB) Stipulation Order to Stay Litigation With Respect to Lupin, Ltd and Lupin Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 11/30/2024. Associated Cases: 1:22-cv-01461-CJB, 1:23-cv-00964-CJB(dlb) | PACER Document |
| Nov 30, 2023 | Case Stayed (dlb) | PACER Document |
| Sep 1, 2023 | Summons Issued as to Lupin Ltd. and Lupin Pharmaceuticals, Inc. on 9/1/2023. (Attachments: # 1 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |
| Sep 1, 2023 | COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4214674.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Civil Cover Sheet)(jfm) (Entered: 09/01/2023) | Attachment |